TEAR - TearLab Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue24,99927,11928,01425,156
Cost of Revenue8,49510,59110,18810,825
Gross Profit16,50416,52817,82614,331
Operating Expenses
Research Development3,5874,6915,1526,951
Selling General and Administrative9,49420,78025,45434,284
Non Recurring----
Others----
Total Operating Expenses22,53738,18343,99055,293
Operating Income or Loss2,462-11,064-15,976-30,137
Income from Continuing Operations
Total Other Income/Expenses Net-4,713-5,037-3,944-3,092
Earnings Before Interest and Taxes2,462-11,064-15,976-30,137
Interest Expense--4,269-4,003-2,023
Income Before Tax-2,251-16,101-19,920-33,229
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-2,251-16,101-19,920-33,229
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-2,251-16,101-19,920-33,229
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-2,251-16,101-19,920-33,229